Synthetic Peptide APIs Portfolio
Product Description
CuraTeQ Biologics
-
IN -
2024On CPHI since
-
250 - 499Employees
Company types
Primary activities
Categories
Specifications
CuraTeQ Biologics
-
IN
-
2024On CPHI since
-
250 - 499Employees
Company types
Primary activities
More Products from CuraTeQ Biologics (1)
-
Product Biosimilars Portfolio
• Pegfilgrastim (Filed with EMA) • Filgrastim (Filed with EMA) • Trastuzumab (Filed with EMA, MHRA, Received recommendation for marketing authorization in India) • Bevacizumab (Filed with MHRA) • Omalizumab (Global PhIII ongoing) • Denosumab (Global PhIII ongoing) • Ranibizumab (Global PhIII ongoing...
CuraTeQ Biologics resources (1)
-
Brochure Synthetic Peptide APIs Portfolio
Auro Peptides, our synthetic peptides arm, has filed 14 US DMFs which have contributed to 6 ANDA approvals.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance